Genotype association of C(-735)T polymorphism of the MMP-2 gene with the risk of carotid atherosclerosis-vulnerable plaque in the Han Chinese population

Vascular Medicine

Volumn 16, Issue 1, 2011, Pages 13-18

  Wang, Feng ^a   Jin, Xiao Ping ^a   Zhu, Min ^a   Lin, Xian Fang ^a   Hu, Xiao Fei ^a   Wang, Wan Fen ^a   Han, Zhao ^a   Huang, Ling Zhi ^a  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

carotid atherosclerosis; genetic polymorphism; matrix metalloproteinase 2; vulnerable plaque

Indexed keywords

GELATINASE A;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHINESE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CAROTID ARTERY DISEASES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMODYNAMICS; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; PLAQUE, ATHEROSCLEROTIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79954469080     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X10394237     Document Type: Article

References (18)

1. Galis ZS, Khatri JJ Matrix metalloproteinase in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002 ; 90: 251-262. (Pubitemid 34633925)
2. Li Z., Li L., Zielke HR, et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 1996 ; 148: 121-128. (Pubitemid 26019650)
3. Yu C., Zhou Y., Miao X., Xiong P., Tan W., Lin D. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res 2004 ; 64: 7622-7628. (Pubitemid 39372109)
4. Mathiesen EB, Bønaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromsø study. Circulation 2001 ; 103: 2171-2175. (Pubitemid 32458326)
5. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003 ; 108 ; 1664-1672. (Pubitemid 37243650)
6. Derosa G., D'Angelo A., Ciccarelli L., et al. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium 2006 ; 13: 227-231. (Pubitemid 44110588)
7. Huhtala P., Chow LT, Tryggvason K. Structure of the human type IV collagenase gene. J Biol Chem 1990 ; 265: 11, 077-11, 082.
8. Egeblad M., Werb Z. New functions for the matrixmetalloproteinases in cancer progression. Nat Rev Cancer 2002 ; 2: 161-174. (Pubitemid 37328786)
9. Ehringer WD, Wang OL, Haq A., Miller FN Bradykinin and alpha-thrombin increase human umbilical vein endothelial macromolecular permeability by different mechanisms. Inflammation 2000 ; 24: 175-193. (Pubitemid 30127821)
10. Heo JH, Lucero J., Abumiya T., Koziol JA, Copeland BR, del Zoppo GJ Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. Cereb Blood Flow Metab 1999 ; 19: 624-633. (Pubitemid 30161214)
11. Thrailkill KM, Bunn RC, Moreau CS, et al. Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care 2007 ; 30: 2321-2326. (Pubitemid 47359041)
12. Momi S., Falcinelli E., Giannini S., et al. Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. J Exp Med 2009 ; 206: 2365-2379.
13. Fatar M., Stroick M., Steffens M., et al. Single-nucleotide polymorphisms of mmp-2 gene in stroke subtypes. Cerebrovasc Dis 2008 ; 26: 113-119.
14. Kang S., Zhao X., Xing H., et al. Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis. Environ Mol Mutagen 2008 ; 49: 226-231. (Pubitemid 351499913)
15. Vask A., Goldbergová M., Izakovicová Hollá L., et al. A haplotype constituted of four MMP-2 promoter polymorphisms is associated with coronary triple-vessel disease. Matrix Biol 2004 ; 22: 585-591. (Pubitemid 38283782)
16. Zhou Y., Yu C., Miao X., et al. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility. Carcinogenesis 2005 ; 26: 1117-1121. (Pubitemid 41214305)
17. Huang X., Jin X., Zhu M., Lin X., Zhang D., Ye Z. The relationship between the polymorphism of the MMP-3 gene and the vulnerability of carotid atherosclerosis in Chinese Han population. Chinese J Neurol 2009 ; 42: 233-236.
18. Armstrong C., Abilleira S., Sitzer M., Markus HS, Bevan S. Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness. Stroke 2007 ; 38: 2895-2899. (Pubitemid 350035681)